Biossil
Toronto, CA · 2 known investors
biossil is an AI-native biopharma company developing late-stage drug programs for life-threatening conditions with unmet needs, including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer's disease. It applies gene embedding analysis to drug discovery, rescue, and repositioning, with active and planned clinical trials across a range of rare and severe indications.
AI & Machine LearningBiotechHealthtech
Founders & leadership
AI
Alexander I. MosaMD PhD
AM
Anthony MouchantafJD MBA
Investors · 2
Frequently asked questions
- What does Biossil do?
- biossil is an AI-native biopharma company developing late-stage drug programs for life-threatening conditions with unmet needs, including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer's disease. It applies gene embedding analysis to drug discovery, rescue, and repositioning, with active and planned clinical trials across a range of rare and severe indications.
- Who are Biossil's investors?
- Biossil's investors include Founders Fund, Panache Ventures.
- Where is Biossil headquartered?
- Biossil is headquartered in Toronto, CA.